Sonnet Biotherapeutics
Price & Volume
Stats
See more52W Range | $1.30-$16.80 |
Market Cap | $4.1M |
Shares Short | 79,670 |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | 5,268.8% |
Gross Profit (12 Mos) | -$351,390 |
Diluted EPS | -$10.22 |
News
See moreYahoo Finance • yesterday
Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas
Yahoo Finance • 8 days ago
Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein
Yahoo Finance • 16 days ago
Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
About
CEO | Dr. Pankaj Mohan Ph.D. |
CFO | Mr. Donald J. Griffith CPA, CPA |
Address | 100 Overlook Center, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
